输液过滤|药液过滤器|静脉输液过滤器|颇尔中国官网

自 1960 年以来，颇尔一直致力于优化输液治疗

欢迎了解颇尔先进的静脉输液(IV)过滤系统

静脉输注药物是一种常见的疗法，常常可以挽救生命。但遗憾的是，向患者体内输入这些药物时，很可能会无意间同时输入环境空气、细菌、内毒素及颗粒物等，对患者的健康造成危害。^1-4

颇尔 IV过滤器能够在哪些领域发挥作用

实验和临床研究证明，颇尔 IV过滤装置能够截留颗粒、气泡、微生物及相关内毒素。^5-7 此外，使用 IV过滤器还可提升疗效、缩短 ICU 患者的住院时间，进而提高医院的整体收益。^8-13

无论是过去、现在还是将来，颇尔一直大力支持有关 IV过滤装置的研究。其中一些研究的成果甚至被写入了国家及国际指南，例如，美国肠外肠内营养学会 (ASPEN) 和美国静脉输液护理学会 (INS) 便指出：

“应考虑对溶液和药物进行过滤，以减少危重症患者体内的颗粒物，因为这些颗粒物可能导致血栓形成、微循环受损和免疫反应改变。”(INS 2021)¹⁶
“那些不过滤肠外营养 (PN) 混合物或静脉输注用脂质乳剂 (ILE) 的医疗保健机构应重新评估这些决定，与因未过滤 ILE 或 PN 导致的发病率和死亡率上升相比，使用过滤器的成本要低得多。” (A.S.P.E.N. 2020)¹⁵
“需采用输液过滤器来实施肠外给药，以减小微粒、微沉淀、微生物和空气栓塞导致患者受到伤害的可能性。” (A.S.P.E.N. 2014) ¹

我们持续关注患者安全和满意度，相信我们在 IV过滤装置方面的专业知识以及我们与广大客户和临床机构的合作，将一如既往推动优化全球范围内的输液治疗。

参考文献

Myers G.J. (2017). Air in intravenous lines: a need to review old opinions. Perfusion; 32 (6): 432-435
A. F. Merry A.F., Gargiulo D.A., Fry L.E. (2017). What are we injecting with our drugs? Anaesth Intensive Care; 45 (5): 539-542
Holmes C.J., Kundsin R.B., Ausman R.K., Walter C.W. (1980). Potential hazards associated with microbial contamination of in-line filters during intravenous therapy. J Clin Microbiol;12 (6): 725-731
Perez M., Maiguy-Foinard A., Barthélémy C., Décaudin B., Odou P. (2016). Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharm. Technol. Hosp. Pharm.; 1(2): 91-103
Perez M. et al. (2018). Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol. Sci Rep; 8 (7714): 1 - 8
Van Lingen R.A., Baerts W., Marquering A.C., Ruijs G.J. (2004). The use of in-line intravenous filters in sick newborn infants. Acta Paediatr; 93 (5): 658-62
Richards C., Grassby P.F. (1994). A comparison of the endotoxin-retentive abilities of two '96-h' in-line intravenous filters. J Clin Pharm Ther;19 (3): 199-202
Jack T. et al. (2012). In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial. Intensive Care Med, 38, 1008-1016
Boehne M. et al. (2013). In-line filtration minimizes organ dysfunction: New aspects from a prospective, randomized, controlled trial. BMC Pediatrics, 13 (21): 1-8
Sasse M. et al. (2015). In-line Filtration Decreases Systemic Inflammatory Response Syndrome, Renal and Hematologic Dysfunction in Pediatric Cardiac Intensive Care Patients. Pediatr Cardiol; 36: 1270-1278
Villa G. et al. (2018). In-Line Filtration Reduces Postoperative Venous Peripheral Phlebitis Associated With Cannulation: A Randomized Clinical Trial. Anesth Analg; 127(6): 1367-1374
Unger-Hunt L. (2019). Reducing Risks and Generating Economic Benefits. Health Management; 19 (4): 286-287
Schmitt E. et al. (2019). In-line filtration of intravenous infusion may reduce organ dysfunction of adult critical patients. Crit Care; 23(1): 373
Ayers P. et al. (2014) A.S.P.E.N. Parenteral Nutrition Safety Consensus Recommendations. Journal of Parenteral and Enteral Nutrition; 38 (3): 296-333
Worthington P. et al. (2020). Update on the Use of Filters for Parenteral Nutrition: An ASPEN Position Paper. Nutrition in Clinical Practice; 0 (0): 1 - 11
Gorski L.A. et al. (2021). Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs; 01(44): S1-S224